FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/07/055053 [Registered on: 11/07/2023] Trial Registered Prospectively
Last Modified On: 07/07/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Diagnostic
Preventive 
Study Design  Single Arm Study 
Public Title of Study   Sarpagandha ghanvati will be given to patients of High blood pressure  
Scientific Title of Study   Clinical evaluation of sarpagandha ghanvati in hypertension  
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Manisha  
Designation  PG Scholar 
Affiliation  Uttarakhand ayurved university gurukul campus haridwar  
Address  Opd 05 department of kayachikitsa uttarakhand ayurved university gurukul campus haridwar

Hardwar
UTTARANCHAL
249404
India 
Phone  8546890482  
Fax    
Email  manisha1995tamta@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Punita Pandey  
Designation  Professor  
Affiliation  Uttrakhand Ayurved University Gurukul Campus Haridwar  
Address  OPD 05 Department Of Kayachikitsa Uttarakhand Ayurved University Gurukul Campus Haridwar

Hardwar
UTTARANCHAL
249404
India 
Phone  9215074978  
Fax    
Email  pandey.punita62@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Manisha 
Designation  PG Scholar 
Affiliation  Uttarakhand Ayurved University Gurukul Campus Haridwar  
Address  Opd 05 department of kayachikitsa uttarakhand ayurved university gurukul campus haridwar

Hardwar
UTTARANCHAL
249404
India 
Phone  8546890482  
Fax    
Email  manisha1995tamta@gmail.com  
 
Source of Monetary or Material Support  
Uttrakhand ayurved University gurukul campus haridwar  
 
Primary Sponsor  
Name  MANISHA 
Address  OPD 05 PG DEPARTMENT OF KAYACHIKITSA UTTARAKHAND AYURVED UNIVERSITY GURUKUL CAMPUS HARIDWAR 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr MANISHA  UAU,GURUKUL CAMPUS HARIDWAR  OPD 05 PG DEPARTMENT OF KAYACHIKITSA UTTARAKHAND AYURVED UNIVERSITY GURUKUL CAMPUS HARIDWAR
Hardwar
UTTARANCHAL 
8546890482

manisha1995tamta@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:I10||Essential (primary) hypertension. Ayurveda Condition: RAKTAVRUTAVATAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Sarpagandha ghan vati , Reference: Siddhayoga sangraha, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 250(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: Lukewarm Water ), Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Patients of either sex with age between 18-70 years
Patients having Systolic Blood Pressure is more than 140 and less than 180 mm of Hg
Patients having Diastolic Blood Pressure is more than 90 and less than or equal to 110 mm of Hg
 
 
ExclusionCriteria 
Details  Patients of either sex below 18 years & above 70 years will be excluded from the study
Patients having Systolic Blood Pressure is more than 180mm of Hg
Patients having Diastolic Blood Pressure is more than 110mmHg
Patients suffering from serious comorbidities like Renal failure, Coronaryartery disease, endocrinal disorder, congestive heart disease
Pregnant woman
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
a) Headache
b) Giddiness
c) Palpitations
d) Breathlessness
e) Insomnia
 
Assessment willl be done weekly for 8 weeks
 
 
Secondary Outcome  
Outcome  TimePoints 
1. systolic blood pressure
2. diastolic blood pressure 
Assessment of the patients will be done weekly for 8 weeks  
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   17/07/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="9"
Days="10" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is a open label clinical trial to determine the efficacy of sarpagandha ghanvati in hypertension for the age group between 18 to 70 years for 45 days.Study will be conducted at UAU, Gurukul Campus, Haridwar on 40 patients. Assessment will be done on the basis of subjective and objective parameters. Study will be conducted at OPD/IPD level of PG department of Kayachikitsa. Assessment will be done at weekly interval and result obtained will be analyzed using appropriate tests  
Close